Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Oral repeated-dose toxicity studies of coenzyme Q10 in beagle dogs.

Yerramilli-Rao P, Beal MF, Watanabe D, Kieburtz K, Blieck EA, Kitano M, Hosoe K, Funahashi I, Cudkowicz ME.

Int J Toxicol. 2012 Jan-Feb;31(1):58-69. doi: 10.1177/1091581811425256. Epub 2012 Jan 20.

2.

Subchronic oral toxicity of ubiquinol in rats and dogs.

Kitano M, Watanabe D, Oda S, Kubo H, Kishida H, Fujii K, Kitahara M, Hosoe K.

Int J Toxicol. 2008 Mar-Apr;27(2):189-215. doi: 10.1080/10915810801978060.

PMID:
18404543
3.

A randomized, double-blind, crossover study on the pharmacokinetics of a novel formulation of CoQ₁₀ with pyridoxal 5'-phosphate and phosphatidyl choline.

Evans M, Sharma P, Guthrie N.

J Diet Suppl. 2010 Dec;7(4):314-24. doi: 10.3109/19390211.2010.522551. Epub 2010 Oct 11.

PMID:
22432561
4.

Total coenzyme Q10 concentrations in Asian men following multiple oral 50-mg doses administered as coenzyme Q10 sustained release tablets or regular tablets.

Lu WL, Zhang Q, Lee HS, Zhou TY, Sun HD, Zhang DW, Zheng L, Lee M, Wong SM.

Biol Pharm Bull. 2003 Jan;26(1):52-5.

5.

Pharmacokinetic comparison of a generic coenzyme Q₁₀ solubilizate and a formulation with soybean phytosterols.

Young JM, Molyneux SL, Florkowski CM, Frampton CM, George PM, Scott RS.

Phytother Res. 2012 Jul;26(7):1092-6. doi: 10.1002/ptr.3667. Epub 2012 Jan 6.

PMID:
22228560
6.

Bioavailability of four oral coenzyme Q10 formulations in healthy volunteers.

Weis M, Mortensen SA, Rassing MR, Møller-Sonnergaard J, Poulsen G, Rasmussen SN.

Mol Aspects Med. 1994;15 Suppl:s273-80.

PMID:
7752839
7.

Enhanced oral bioavailability of Coenzyme Q10 by self-emulsifying drug delivery systems.

Balakrishnan P, Lee BJ, Oh DH, Kim JO, Lee YI, Kim DD, Jee JP, Lee YB, Woo JS, Yong CS, Choi HG.

Int J Pharm. 2009 Jun 5;374(1-2):66-72. doi: 10.1016/j.ijpharm.2009.03.008. Epub 2009 Mar 19.

PMID:
19446761
8.

Thirteen-week repeated dose oral toxicity study of coenzyme Q10 in rats.

Honda K, Tominaga S, Oshikata T, Kamiya K, Hamamura M, Kawasaki T, Wakigawa K.

J Toxicol Sci. 2007 Oct;32(4):437-48.

9.

Novel solid self-emulsifying drug delivery system of coenzyme Q₁₀ with improved photochemical and pharmacokinetic behaviors.

Onoue S, Uchida A, Kuriyama K, Nakamura T, Seto Y, Kato M, Hatanaka J, Tanaka T, Miyoshi H, Yamada S.

Eur J Pharm Sci. 2012 Aug 15;46(5):492-9. doi: 10.1016/j.ejps.2012.03.015. Epub 2012 Apr 3.

PMID:
22498005
10.

Toxicity of coenzyme Q(10): a report of 90-day repeated dose toxicity study in rats.

Zhipeng W, Mingkai L, Shuyu C, Min J, Jingru M, Xue M, Yumei W, Xiaoxing L.

J Toxicol Sci. 2007 Dec;32(5):505-14.

11.

Estimation of plasma and saliva levels of coenzyme Q10 and influence of oral supplementation.

Sekine K, Ota N, Nishii M, Uetake T, Shimadzu M.

Biofactors. 2005;25(1-4):205-11.

PMID:
16873948
12.

Safety and tolerability of high-dosage coenzyme Q10 in Huntington's disease and healthy subjects.

Huntington Study Group Pre2CARE Investigators, Hyson HC, Kieburtz K, Shoulson I, McDermott M, Ravina B, de Blieck EA, Cudkowicz ME, Ferrante RJ, Como P, Frank S, Zimmerman C, Cudkowicz ME, Ferrante K, Newhall K, Jennings D, Kelsey T, Walker F, Hunt V, Daigneault S, Goldstein M, Weber J, Watts A, Beal MF, Browne SE, Metakis LJ.

Mov Disord. 2010 Sep 15;25(12):1924-8. doi: 10.1002/mds.22408.

PMID:
20669312
13.

Physicochemical and pharmacokinetic characterization of water-soluble Coenzyme Q(10) formulations.

Hatanaka J, Kimura Y, Lai-Fu Z, Onoue S, Yamada S.

Int J Pharm. 2008 Nov 3;363(1-2):112-7. doi: 10.1016/j.ijpharm.2008.07.019. Epub 2008 Jul 29.

PMID:
18706989
14.

Validated HPLC method for the quantitative determination of CoQ(10) in dog plasma and its application to a pharmacokinetic study.

Yuan B, Liu C, Xu P, Lin L, Pan C, Wang L, Xu H.

Biomed Chromatogr. 2011 Sep;25(9):1038-44. doi: 10.1002/bmc.1567. Epub 2010 Dec 10.

PMID:
21154890
16.

Combined effect of coenzyme Q10 and fenofibrate on forearm microcirculatory function in type 2 diabetes.

Playford DA, Watts GF, Croft KD, Burke V.

Atherosclerosis. 2003 May;168(1):169-79.

PMID:
12732401
17.
18.

Comparative bioavailability of two novel coenzyme Q10 preparations in humans.

Joshi SS, Sawant SV, Shedge A, Halpner AD.

Int J Clin Pharmacol Ther. 2003 Jan;41(1):42-8.

PMID:
12564745
19.

Randomized, double-blind, placebo-controlled trial of coenzyme Q10 in isolated systolic hypertension.

Burke BE, Neuenschwander R, Olson RD.

South Med J. 2001 Nov;94(11):1112-7.

PMID:
11780680
20.

Emulsification of coenzyme Q10 using gum arabic increases bioavailability in rats and human and improves food-processing suitability.

Ozaki A, Muromachi A, Sumi M, Sakai Y, Morishita K, Okamoto T.

J Nutr Sci Vitaminol (Tokyo). 2010;56(1):41-7.

Supplemental Content

Support Center